J. Lipid Res. Did you know there is a large type edition? Click here.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1194/jlr.M600078-JLR200 on April 19, 2006

Papers In Press, published online ahead of print July 1, 2006
J. Lipid Res., doi:10.1194/jlr.M600078-JLR200
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
M600078-JLR200v1
47/7/1457    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kullo, I. J.
Right arrow Articles by de Andrade, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kullo, I. J.
Right arrow Articles by de Andrade, M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 47, 1457-1462, July 2006
Copyright © 2006 by American Society for Biochemistry and Molecular Biology

Quantitative trait loci influencing low density lipoprotein particle size in African Americans

Iftikhar J. Kullo1,*, Keyue Ding*, Eric Boerwinkle{dagger}, Stephen T. Turner§ and Mariza de Andrade**

* Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN 55905
§ Division of Nephrology and Hypertension, Mayo Clinic and Foundation, Rochester, MN 55905
** Division of Biostatistics, Mayo Clinic and Foundation, Rochester, MN 55905
{dagger} Human Genetics Center and Institute of Molecular Medicine, University of Texas-Houston Health Science Center, Houston, TX 77030

Published, JLR Papers in Press, April 19, 2006.

1 To whom correspondence should be addressed. e-mail: kullo.iftikhar{at}mayo.edu


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Genomic regions that influence LDL particle size in African Americans are not known. We performed family-based linkage analyses to identify genomic regions that influence LDL particle size and also exert pleiotropic effects on two closely related lipid traits, high density lipoprotein cholesterol (HDL-C) and triglycerides, in African Americans. Subjects (n = 1,318, 63.0 ± 9.5 years, 70% women, 79% hypertensive) were ascertained through sibships with two or more individuals diagnosed with essential hypertension before age 60. LDL particle size was measured by polyacrylamide gel electrophoresis, and triglyceride levels were log-transformed to reduce skewness. Genotypes were measured at 366 microsatellite marker loci distributed across the 22 autosomes. Univariate and bivariate linkage analyses were performed using a variance components approach. LDL particle size was highly heritable (h2 = 0.78) and significantly (P < 0.0001) genetically correlated with HDL-C ({rho}G = 0.32) and log triglycerides ({rho}G = –0.43). Significant evidence of linkage for LDL particle size was present on chromosome 19 [85.3 centimorgan (cM), log of the odds (LOD) = 3.07, P = 0.0001], and suggestive evidence of linkage was present on chromosome 12 (90.8 cM, LOD = 2.02, P = 0.0011). Bivariate linkage analyses revealed tentative evidence for a region with pleiotropic effects on LDL particle size and HDL-C on chromosome 4 (52.9 cM, LOD = 2.06, P = 0.0069). These genomic regions may contain genes that influence interindividual variation in LDL particle size and potentially coronary heart disease susceptibility in African Americans.

Supplementary key words bivariate • genetic linkage • high density lipoprotein cholesterol • triglycerides


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Low-density lipoprotein particles vary in size, and smaller LDL particles are considered to be more atherogenic than larger particles (1–4). Together with decreased high density lipoprotein cholesterol (HDL-C) and increased triglyceride levels, small LDL particle size constitutes the syndrome of atherogenic dyslipidemia, which is associated with a significant increase in the risk for coronary heart disease (5, 6). Several studies have investigated the genetic basis of LDL particle size [reviewed by Bosse, Perusse, and Vohl (7)]. Most of the studies have been limited to non-Hispanic whites, and genomic regions that influence interindividual variation in LDL particle size in African Americans are unknown. African Americans have lower levels of triglycerides and higher levels of HDL-C than do non-Hispanic whites (8), and Haffner et al. (9) reported that LDL particle size may also vary with ethnicity. Thus, the genetic determinants of LDL particle size in African Americans cannot be extrapolated from studies in other ethnic groups and will need further delineation.

Because of the well-recognized correlation between LDL particle size, HDL-C, and triglycerides, it is likely that genes with pleiotropic effects on these lipid traits exist. We (10) and others (11) have demonstrated that shared genetic effects (pleiotropy) account for a significant proportion of the phenotypic correlations between LDL particle size, HDL-C, and triglycerides. Therefore, in addition to univariate linkage analyses to identify genetic regions that influence LDL particle size, we performed bivariate linkage analyses in African American sibships to identify additional regions that may exert pleiotropic effects on pairwise combinations of LDL particle size, HDL-C, and triglycerides. Such studies have the potential to yield new insights into the genetic basis of the interindividual variation of LDL particle size and the susceptibility to coronary heart disease in African Americans (12).


   METHODS
TOP
 ABSTRACT
 INTRODUCTION
 METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Sample
Subjects included African Americans from Jackson, Mississippi, participating in the Genetic Epidemiology Network of Arteriopathy (GENOA) study, a multicenter, community-based study of hypertensive sibships that aims to identify genes influencing blood pressure levels and the development of target organ damage as a result of hypertension (13). Recruitment into the initial phase of the GENOA study (September 1995 to June 2001) has been described previously (14). Between December 2000 and October 2004, 1,350 of the original GENOA-Jackson participants returned for a second study visit to undergo measurement of risk factors and traits, including LDL particle size and assessment of target organ damage resulting from hypertension. Genotypic (microsatellite markers) and phenotypic (LDL particle size) data were available for 1,318 Jackson participants in phase II. The study was approved by the Institutional Review Board of the University of Mississippi (Jackson). Written informed consent was obtained from each participant.

Height was measured by stadiometer, weight by electronic balance, and body mass index (BMI) was calculated as kg/m2. Resting systolic and diastolic blood pressure levels were measured in the right arm with a random-zero sphygmomanometer (Hawksley and Sons, West Sussex, UK). Participants were considered diabetic if they reported using insulin or oral hypoglycemic agents or if they reported a physician diagnosis of diabetes but were not currently taking a pharmacological agent to control their high glucose levels. Information about the use of lipid-lowering medications was obtained from participants at the time of the study.

Measurement of lipid variables
Blood samples were obtained by venipuncture after an overnight fast. Standard enzymatic methods were used to measure total cholesterol, HDL-C, and triglycerides (15). LDL particle size was measured by polyacrylamide gel electrophoresis as described previously (16, 17). The mean LDL particle size was then determined by averaging weighted diameters for each fraction. Two controls (mean particle diameters of 264 and 254 Å) were analyzed with every 10 study samples. Interassay coefficients of variation were 0.77% (SD = 2.0 Å) and 1.46% (SD = 3.7 Å), respectively.

Genotyping
DNA was extracted from 10 ml of EDTA-anticoagulated blood drawn from all study participants according to standard procedures. Microsatellite markers (CHLC/Weber screening set 9.0, n = 366) were genotyped using standard PCR-based methods by the Mammalian Genotyping Center of the Marshfield Medical Research Foundation. Marker order and genetic map distances were those provided by the Marshfield Medical Research Foundation (research.marshfieldclinic.org/genetics/). Inconsistencies of the genotypes with pedigree structure were identified by the Lange and Goradia algorithm (18) as implemented in the PedCheck software (19). Instances that could not be resolved as genotyping errors were considered as missing data.

Statistical analyses
Before genetic linkage analyses, we assessed whether the assumption of normality in the distribution of each lipid trait was violated (20). Triglyceride levels were positively skewed and were therefore log-transformed. LDL particle size, HDL-C, and log triglycerides were adjusted for age, sex, BMI, diabetes, history of smoking, and statin use in the genetic analyses. Genetic and environmental correlations between adjusted lipid traits were estimated by variance decomposition using maximum likelihood methods (21), and the phenotypic correlations between traits were calculated based on genetic and environmental correlations (22). The heritability (h2) of each trait was calculated as the proportion of the total phenotypic variance attributable to additive genetic effects.

Univariate and bivariate linkage analyses were performed using the S-Plus library Multic, which employs a multivariate variance components approach that is an extension of the univariate approach described by Amos (23) and de Andrade et al. (24). Multipoint identity-by-descent sharing among pairs of relatives was calculated using the SIMWALK2 software program (25). This program estimates multipoint identity-by-descent probabilities using an alternative Markov chain Monte Carlo algorithm to efficiently accommodate large sibships and provides estimates in agreement with deterministic methods.

To test for genetic linkage, a likelihood ratio test (LRT) was used in which the LRT is defined as –2x[(log likelihood under the null hypothesis) – (log likelihood under the alternative hypothesis)]. Under the null hypothesis, the linked gene parameter(s) are restricted to equal zero ({sigma}g.ij are zero for all i,j). For the bivariate linkage analysis, the distribution of the bivariate test that the linked-gene components and covariance are zero is a mixture ofFormula, as described by Self and Liang (26).

All log of the odds (LOD) scores for the multipoint linkage analyses were calculated from the LRT values as LRT/(2 x ln[10]). For the univariate linkage analyses of LDL particle size, HDL-C, and log triglycerides, we considered multipoint LOD scores of >=3.00 as statistically significant evidence of linkage, scores of >=2.00 as suggestive evidence of linkage, and scores of >=1.30 as tentative evidence of linkage (27). These multipoint LOD score thresholds correspond to genome-wide P values of <=0.0001, <=0.001, and <=0.007, respectively (27). Bivariate linkage analyses were performed for each pairwise combination of the traits. To achieve levels of statistical significance comparable to the univariate linkage thresholds, we considered bivariate LOD scores of >=4.00 as statistically significant evidence of linkage, scores of >=2.87 as suggestive evidence of linkage, and scores of >=2.06 as tentative evidence of linkage. These higher bivariate thresholds were calculated using asymptotic values of a mixture of Formula distribution. We considered a region to have possible pleiotropic effects if the bivariate LOD score was at least 2.06 and the P value was less than either of the univariate maxima.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
The study sample of 1,318 subjects belonged to 674 sibships and included 1,133 sibpairs; there were 312 sibships of size 1, 201 sibships of size 2, and 161 sibships of size 3 or greater. Seventy percent of the subjects were women, 71% were hypertensive, and 18.3% were on lipid-lowering medications (Table 1 ).


View this table:
[in this window]
[in a new window]
  		TABLE 1. Descriptive characteristics of the subjects (n = 1,318)

 
Heritability and genetic correlations
LRT results indicated significant heritability (P < 0.001) for each of the three lipid traits: LDL particle size, HDL-C, and triglycerides (Table 2 ). After adjustment for age, sex, BMI, diabetes, history of smoking, and statin use, more than three-quarters of the residual variance in LDL particle size, more than half of the residual variance in HDL-C, and more than one-third of the residual variance in log triglycerides was attributable to additive genetic effects (Table 2).


View this table:
[in this window]
[in a new window]
  		TABLE 2. Heritabilities (on the diagonal), phenotypic correlations (above the diagonal), and genetic correlations (below the diagonal) of the three lipid traits

 
Genetic correlations between the three lipid traits were significantly different from zero (P < 0.0001) based on LRT results (Table 2). The genetic correlations between LDL particle size and log triglycerides ({rho}G = –0.43) and between HDL-C and log triglycerides ({rho}G = –0.57) were negative, whereas the genetic correlation between LDL particle size and HDL-C was positive ({rho}G = 0.32).

Linkage analyses
In univariate linkage analyses, there was suggestive evidence of linkage for LDL particle size near D12S1064 on chromosome 12q21 [90.8 centimorgan (cM), LOD = 2.02, P = 0.0011] (Table 3 , Fig. 1A ). Significant evidence of linkage for LDL particle size was observed near D19S589 on chromosome 19q13 (85.3 cM, LOD = 3.07, P = 0.0001) (Table 3, Fig. 1B). Univariate linkage analyses of HDL-C demonstrated tentative evidence of linkage on chromosome 7q35 (159.1 cM, LOD = 1.32, P = 0.0068) and 10q21 (81.5 cM, LOD = 1.48, P = 0.0046). For log triglycerides, there was tentative evidence of linkage on chromosome 8q21 (104.3 cM, LOD = 1.64, P = 0.0030) (Table 3).


View this table:
[in this window]
[in a new window]
  		TABLE 3. Maximum multipoint LOD scores (and positions in cM) and P values for the univariate and bivariate linkage analyses LDL particle size, HDL-C, and log triglycerides

 

Figure 1
View larger version (7K):
[in this window]
[in a new window]
  		Fig. 1. Results of univariate multipoint variance component linkage analyses for LDL particle size on the chromosome 12 (A) and chromosome 19 (B). Markers adjacent to the log of the odds-1 (LOD-1) interval are shown along the top of each plot. cM, centimorgan.

 
Bivariate linkage analyses identified a region near D4S2632 on chromosome 4p15 that may have pleiotropic effects on LDL particle size and HDL-C (52.9 cM, bivariate LOD = 2.06, P = 0.0069) (Table 3, Fig. 2A , B). There was suggestive evidence of pleiotropic effects on the pairwise combination of HDL-C and log triglycerides on two chromosomes: chromosome 4q13 (75.9 cM, bivariate LOD = 3.17, P = 0.0006) (Fig. 2A, B) and chromosome 16 (91.0 cM, bivariate LOD = 2.29, P = 0.0042) (Fig. 2C, D).


Figure 2
View larger version (17K):
[in this window]
[in a new window]
  		Fig. 2. Results of univariate (A, C) and bivariate (B, D) multipoint variance component linkage analyses for the three lipid traits on chromosome 4 (A, B) and chromosome 16 (C, D). Markers adjacent to the LOD-1 interval are shown along the top of each plot. HDL-C, high density lipoprotein cholesterol; TG, triglycerides.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
This study is the first to report heritability and linkage analyses for LDL particle size in African Americans. Numerous analyses have been performed to assess the heritability of LDL particle size in either twin (28, 29) or family studies (30–33). These studies, comprising mostly non-Hispanic whites or Hispanics, found that 30–60% of the variance in LDL particle size was attributable to genetic factors. We found LDL particle size to be significantly heritable in African Americans: 78% of the variance in LDL particle size could be attributed to additive genetic effects.

Although linkage scans for genetic loci affecting LDL particle size have been performed in several previous studies (Table 4 ), none of these included African Americans. In this study of African American sibships ascertained on the basis of hypertension, we found significant evidence of linkage (LOD = 3.07) of chromosome 19q13 (LOD-1 interval: 73.3–96.7 cM) (Fig. 1B). Allayee et al. (34) found tentative evidence for linkage for peak LDL particle size in this region of chromosome 19q13 (78.1 cM, LOD = 1.6) in Dutch Caucasian families. These results suggest the presence of a quantitative trait locus on chromosome 19q13 that influences LDL particle size. The linkage peak for LDL particle size on chromosome 12q21 (LOD = 2.02) (Fig. 1A) appears to be novel and has not been reported previously. Univariate linkage analyses for HDL-C and log triglycerides yielded only weak linkage signals (LOD < 2.0).


View this table:
[in this window]
[in a new window]
  		TABLE 4. Linkage studies for LDL particle size

 
Bivariate linkage analyses may provide greater statistical power to identify genetic loci with effects too small to be detected in single-trait analyses (35). Using such an approach, we previously found a locus with pleiotropic effects on LDL particle size and HDL-C on chromosome 1 (LOD = 4.48, 4 cM) in non-Hispanic whites participating in the GENOA study (17). In the present study, bivariate analysis of pairwise combinations of the three lipid traits revealed three genomic loci that may have pleiotropic effects on these traits (Fig. 2B, D). In the loci identified, the univariate LOD scores were not suggestive of linkage to any of the individual traits, but the bivariate analyses yielded a higher LOD score with a lower P value than for any of the univariate maxima. Given that common metabolic pathways influence these traits, a gene with pleiotropic effects on the traits, rather than tightly linked genes, is likely to be responsible for the linkage signal of the bivariate phenotype.

An overlap of the bivariate LDL particle size-HDL-C and HDL-C-log triglyceride linkage signals was noted in the chromosome 4q13 region, raising the possibility that the region may have a pleiotropic effect on all three traits. We performed trivariate linkage analyses to assess whether a quantitative trait locus in the region influenced the three lipid traits. A significant increase in the LOD score was not noted, suggesting the presence of two separate loci influencing the LDL particle size-HDL-C and the HDL-C-log triglyceride traits (analyses not shown).

We attempted to identify potential positional candidate genes for the lipid traits in the LOD-1 regions of the linkage signals (i.e., LOD >= 1.3 in univariate and LOD >= 2.06 in bivariate linkage analyses). Of the genes suggested by previous linkage or association studies to influence LDL particle size, an apolipoprotein gene cluster (APOE/C1/C4/C2) was noted to be adjacent to the linkage peak on chromosome 19q13. Two important genes involved in lipid metabolism, CETP (cholesteryl ester transfer protein; chromosome 16q21) and LCAT (lecithin-cholesterol acyltransferase; chromosome 16q22), were present under the HDL-C-log triglyceride bivariate signal on chromosome 16q22. We did not find any obvious candidate genes under the remaining linkage signals.

We also performed a functional network analysis to identify the interaction of known candidate genes for LDL particle size with genes under the linkage signals, using the Ingenuity® Pathway Analysis tool (www.ingenuity.com) (see supplementary figure). Ingenuity® Pathway Analysis is a knowledge-based discovery tool and the largest curated database of previously published findings on mammalian biology (36). Three genes, CLEC11A (C-type lectin domain family 11, member A), KIT (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog), and KITLG (KIT ligand), under the linkage signals on chromosome 19q13, chromosome 4p15, and chromosome 12q21, respectively, interact with the LDL receptor gene (LDLR) shown previously to be a positional candidate gene for LDL particle size (37). In this network, CLEC11A increases the phosphorylation of KIT (38), there is a protein-protein interaction between KIT and KITLG (39), and in turn, KITLG can increase the expression of LDLR (40). These interactions, by affecting LDLR, may influence LDL particle size, although this needs confirmation in additional studies.

In conclusion, our findings indicate the presence of a quantitative trait locus on chromosome 19 that influences LDL particle size in African American sibships ascertained based on hypertension. In addition, there is suggestive evidence for a locus on chromosome 12 that influences this trait and a locus on chromosome 4 that may have pleiotropic effects on LDL particle size and HDL-C. Linkage analysis of LDL particle size and correlated lipid traits is a step toward identifying genetic variants that influence coronary heart disease susceptibility in African Americans.


   ACKNOWLEDGMENTS
 
This work was supported by Grants RR-17720 and HL-75794 to I.J.K., grant HL-54457, and the General Clinical Research Center Grant M01 RR-00585 from the National Institutes of Health.

Manuscript received February 14, 2006 and in revised form April 13, 2006.


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
  1. Freedman, D. S., J. D. Otvos, E. J. Jeyarajah, J. J. Barboriak, A. J. Anderson, and J. A. Walker. 1998. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 18: 1046–1053.[Abstract/Free Full Text]

  2. Kuller, L., A. Arnold, R. Tracy, J. Otvos, G. Burke, B. Psaty, D. Siscovick, D. S. Freedman, and R. Kronmal. 2002. Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the Cardiovascular Health Study. Arterioscler. Thromb. Vasc. Biol. 22: 1175–1180.[Abstract/Free Full Text]

  3. Blake, G. J., J. D. Otvos, N. Rifai, and P. M. Ridker. 2002. Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women. Circulation. 106: 1930–1937.[Abstract/Free Full Text]

  4. Carmena, R., P. Duriez, and J. C. Fruchart. 2004. Atherogenic lipoprotein particles in atherosclerosis. Circulation. 109: III2–III7.

  5. Austin, M. A., J. D. Brunzell, W. L. Fitch, and R. M. Krauss. 1990. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arteriosclerosis. 10: 520–530.[Abstract/Free Full Text]

  6. Reaven, G. M., Y. D. Chen, J. Jeppesen, P. Maheux, and R. M. Krauss. 1993. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J. Clin. Invest. 92: 141–146.[Medline]

  7. Bosse, Y., L. Perusse, and M. C. Vohl. 2004. Genetics of LDL particle heterogeneity: from genetic epidemiology to DNA-based variations. J. Lipid Res. 45: 1008–1026.[Abstract/Free Full Text]

  8. Jain, T., R. Peshock, D. K. McGuire, D. Willett, Z. Yu, G. L. Vega, R. Guerra, H. H. Hobbs, and S. M. Grundy. 2004. African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study. J. Am. Coll. Cardiol. 44: 1011–1017.[Abstract/Free Full Text]

  9. Haffner, S. M., R. D'Agostino, Jr., D. Goff, B. Howard, A. Festa, M. F. Saad, and L. Mykkanen. 1999. LDL size in African Americans, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Arterioscler. Thromb. Vasc. Biol. 19: 2234–2240.[Abstract/Free Full Text]

  10. Kullo, I. J., M. de Andrade, E. Boerwinkle, J. P. McConnell, S. L. Kardia, and S. T. Turner. 2005. Pleiotropic genetic effects contribute to the correlation between HDL cholesterol, triglycerides, and LDL particle size in hypertensive sibships. Am. J. Hypertens. 18: 99–103.[CrossRef][Medline]

  11. Edwards, K. L., M. C. Mahaney, A. G. Motulsky, and M. A. Austin. 1999. Pleiotropic genetic effects on LDL size, plasma triglyceride, and HDL cholesterol in families. Arterioscler. Thromb. Vasc. Biol. 19: 2456–2464.[Abstract/Free Full Text]

  12. Pajukanta, P., H. E. Lilja, J. S. Sinsheimer, R. M. Cantor, A. J. Lusis, M. Gentile, X. J. Duan, A. Soro-Paavonen, J. Naukkarinen, J. Saarela, et al. 2004. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat. Genet. 36: 371–376.[CrossRef][Medline]

  13. The FBPP Investigators. 2002. Multi-center genetic study of hypertension: the Family Blood Pressure Program (FBPP). Hypertension. 39: 3–9.

  14. O'Meara, J. G., S. L. Kardia, J. J. Armon, C. A. Brown, E. Boerwinkle, and S. T. Turner. 2004. Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. Arch. Intern. Med. 164: 1313–1318.[Abstract/Free Full Text]

  15. Kottke, B. A., P. P. Moll, V. V. Michels, and W. H. Weidman. 1991. Levels of lipids, lipoproteins, and apolipoproteins in a defined population. Mayo Clin. Proc. 66: 1198–1208.[Medline]

  16. Hoefner, D. M., S. D. Hodel, J. F. O'Brien, E. L. Branum, D. Sun, I. Meissner, and J. P. McConnell. 2001. Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System. Clin. Chem. 47: 266–274.[Abstract/Free Full Text]

  17. Kullo, I. J., S. T. Turner, E. Boerwinkle, S. L. Kardia, and M. de Andrade. 2005. A novel quantitative trait locus on chromosome 1 with pleiotropic effects on HDL-cholesterol and LDL particle size in hypertensive sibships. Am. J. Hypertens. 18: 1084–1090.[CrossRef][Medline]

  18. Lange, K., and T. M. Goradia. 1987. An algorithm for automatic genotype elimination. Am. J. Hum. Genet. 40: 250–256.[Medline]

  19. O'Connell, J. R., and D. E. Weeks. 1998. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am. J. Hum. Genet. 63: 259–266.[CrossRef][Medline]

  20. de Andrade, M., B. Fridley, E. Boerwinkle, and S. T. Turner. 2003. Diagnostic tools in linkage analysis for quantitative traits. Genet. Epidemiol. 24: 302–308.[CrossRef][Medline]

  21. Lange, K., and M. Boehnke. 1983. Extensions to pedigree analysis. IV. Covariance components models for multivariate traits. Am. J. Med. Genet. 14: 513–524.[CrossRef][Medline]

  22. Jaquish, C. E., M. C. Mahaney, J. Blangero, S. M. Haffner, M. P. Stern, and J. W. MacCluer. 1996. Genetic correlations between lipoprotein phenotypes and indicators of sex hormone levels in Mexican Americans. Atherosclerosis. 122: 117–125.[CrossRef][Medline]

  23. Amos, C. I. 1994. Robust variance-components approach for assessing genetic linkage in pedigrees. Am. J. Hum. Genet. 54: 535–543.[Medline]

  24. de Andrade, M., T. J. Thiel, L. Yu, and C. I. Amos. 1997. Assessing linkage on chromosome 5 using components of variance approach: univariate versus multivariate. Genet. Epidemiol. 14: 773–778.[CrossRef][Medline]

  25. Sobel, E., H. Sengul, and D. E. Weeks. 2001. Multipoint estimation of identity-by-descent probabilities at arbitrary positions among marker loci on general pedigrees. Hum. Hered. 52: 121–131.[CrossRef][Medline]

  26. Self, S., and K-Y. Liang. 1987. Asymptotic properties of maximum likelihood estimators and likelihood ratio tests under non-standard conditions. J. Am. Stat. Assoc. 82: 605–610.[CrossRef]

  27. Morton, N. E. 1998. Significance levels in complex inheritance. Am. J. Hum. Genet. 62: 690–697.[CrossRef][Medline]

  28. Lamon-Fava, S., D. Jimenez, J. C. Christian, R. R. Fabsitz, T. Reed, D. Carmelli, W. P. Castelli, J. M. Ordovas, P. W. Wilson, and E. J. Schaefer. 1991. The NHLBI Twin Study: heritability of apolipoprotein A-I, B, and low density lipoprotein subclasses and concordance for lipoprotein(a). Atherosclerosis. 91: 97–106.[CrossRef][Medline]

  29. Austin, M. A., B. Newman, J. V. Selby, K. Edwards, E. J. Mayer, and R. M. Krauss. 1993. Genetics of LDL subclass phenotypes in women twins. Concordance, heritability, and commingling analysis. Arterioscler. Thromb. 13: 687–695.[Abstract/Free Full Text]

  30. Bosse, Y., M. C. Vohl, J. P. Despres, B. Lamarche, T. Rice, D. C. Rao, C. Bouchard, and L. Perusse. 2003. Heritability of LDL peak particle diameter in the Quebec Family Study. Genet. Epidemiol. 25: 375–381.[CrossRef][Medline]

  31. Barzilai, N., G. Atzmon, C. Schechter, E. J. Schaefer, A. L. Cupples, R. Lipton, S. Cheng, and A. R. Shuldiner. 2003. Unique lipoprotein phenotype and genotype associated with exceptional longevity. J. Am. Med. Assoc. 290: 2030–2040.[Abstract/Free Full Text]

  32. Rainwater, D. L., L. Almasy, J. Blangero, S. A. Cole, J. L. VandeBerg, J. W. MacCluer, and J. E. Hixson. 1999. A genome search identifies major quantitative trait loci on human chromosomes 3 and 4 that influence cholesterol concentrations in small LDL particles. Arterioscler. Thromb. Vasc. Biol. 19: 777–783.[Abstract/Free Full Text]

  33. Austin, M. A., K. L. Edwards, S. A. Monks, K. M. Koprowicz, J. D. Brunzell, A. G. Motulsky, M. C. Mahaney, and J. E. Hixson. 2003. Genome-wide scan for quantitative trait loci influencing LDL size and plasma triglyceride in familial hypertriglyceridemia. J. Lipid Res. 44: 2161–2168.[Abstract/Free Full Text]

  34. Allayee, H., K. M. Dominguez, B. E. Aouizerat, R. M. Krauss, J. I. Rotter, J. Lu, R. M. Cantor, T. W. de Bruin, and A. J. Lusis. 2000. Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia. J. Lipid Res. 41: 245–252.[Abstract/Free Full Text]

  35. Turner, S. T., S. L. Kardia, E. Boerwinkle, and M. de Andrade. 2004. Multivariate linkage analysis of blood pressure and body mass index. Genet. Epidemiol. 27: 64–73.[CrossRef][Medline]

  36. Calvano, S. E., W. Xiao, D. R. Richards, R. M. Felciano, H. V. Baker, R. J. Cho, R. O. Chen, B. H. Brownstein, J. P. Cobb, S. K. Tschoeke, et al. 2005. A network-based analysis of systemic inflammation in humans. Nature. 437: 1032–1037.[CrossRef][Medline]

  37. Rotter, J. I., X. Bu, R. M. Cantor, C. H. Warden, J. Brown, R. J. Gray, P. J. Blanche, R. M. Krauss, and A. J. Lusis. 1996. Multilocus genetic determinants of LDL particle size in coronary artery disease families. Am. J. Hum. Genet. 58: 585–594.[Medline]

  38. Tatton, L., G. M. Morley, R. Chopra, and A. Khwaja. 2003. The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases. J. Biol. Chem. 278: 4847–4853.[Abstract/Free Full Text]

  39. Heinrich, M. C., D. C. Dooley, and W. W. Keeble. 1995. Transforming growth factor beta 1 inhibits expression of the gene products for steel factor and its receptor (c-kit). Blood. 85: 1769–1780.[Abstract/Free Full Text]

  40. Kolbus, A., M. Blazquez-Domingo, S. Carotta, W. Bakker, S. Luedemann, M. von Lindern, P. Steinlein, and H. Beug. 2003. Cooperative signaling between cytokine receptors and the glucocorticoid receptor in the expansion of erythroid progenitors: molecular analysis by expression profiling. Blood. 102: 3136–3146.[Abstract/Free Full Text]

  41. Allayee, H., B. E. Aouizerat, R. M. Cantor, G. M. Dallinga-Thie, R. M. Krauss, C. D. Lanning, J. I. Rotter, A. J. Lusis, and T. W. de Bruin. 1998. Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype. Am. J. Hum. Genet. 63: 577–585.[CrossRef][Medline]

  42. Bosse, Y., L. Perusse, J. P. Despres, B. Lamarche, Y. C. Chagnon, T. Rice, D. C. Rao, C. Bouchard, and M. C. Vohl. 2003. Evidence for a major quantitative trait locus on chromosome 17q21 affecting low-density lipoprotein peak particle diameter. Circulation. 107: 2361–2368.[Abstract/Free Full Text]

  43. Badzioch, M. D., R. P. Igo, Jr., F. Gagnon, J. D. Brunzell, R. M. Krauss, A. G. Motulsky, E. M. Wijsman, and G. P. Jarvik. 2004. Low-density lipoprotein particle size loci in familial combined hyperlipidemia: evidence for multiple loci from a genome scan. Arterioscler. Thromb. Vasc. Biol. 24: 1942–1950.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
A. Malhotra, S. C. Elbein, M. C.Y. Ng, R. Duggirala, R. Arya, G. Imperatore, A. Adeyemo, T. I. Pollin, W.-C. Hsueh, J. C.N. Chan, et al.
Meta-Analysis of Genome-Wide Linkage Studies of Quantitative Lipid Traits in Families Ascertained for Type 2 Diabetes
Diabetes, March 1, 2007; 56(3): 890 - 896.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
M600078-JLR200v1
47/7/1457    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kullo, I. J.
Right arrow Articles by de Andrade, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kullo, I. J.
Right arrow Articles by de Andrade, M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today